JP2025507154A5 - - Google Patents
Info
- Publication number
- JP2025507154A5 JP2025507154A5 JP2024553782A JP2024553782A JP2025507154A5 JP 2025507154 A5 JP2025507154 A5 JP 2025507154A5 JP 2024553782 A JP2024553782 A JP 2024553782A JP 2024553782 A JP2024553782 A JP 2024553782A JP 2025507154 A5 JP2025507154 A5 JP 2025507154A5
- Authority
- JP
- Japan
- Prior art keywords
- drug delivery
- ophthalmic drug
- delivery insert
- approximately
- insert according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263318823P | 2022-03-11 | 2022-03-11 | |
| US63/318,823 | 2022-03-11 | ||
| US202263320984P | 2022-03-17 | 2022-03-17 | |
| US63/320,984 | 2022-03-17 | ||
| US202263341456P | 2022-05-13 | 2022-05-13 | |
| US63/341,456 | 2022-05-13 | ||
| US202263390051P | 2022-07-18 | 2022-07-18 | |
| US63/390,051 | 2022-07-18 | ||
| PCT/US2023/064148 WO2023173093A1 (en) | 2022-03-11 | 2023-03-10 | Continuous dosing regimen for treatment of a condition of the eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507154A JP2025507154A (ja) | 2025-03-13 |
| JP2025507154A5 true JP2025507154A5 (enExample) | 2026-04-07 |
Family
ID=85937358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553782A Pending JP2025507154A (ja) | 2022-03-11 | 2023-03-10 | 眼の状態の治療を目的とした連続投薬レジメン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250186398A1 (enExample) |
| EP (1) | EP4489750A1 (enExample) |
| JP (1) | JP2025507154A (enExample) |
| KR (1) | KR20240156416A (enExample) |
| AU (1) | AU2023230976A1 (enExample) |
| CA (1) | CA3245209A1 (enExample) |
| IL (1) | IL315333A (enExample) |
| TW (1) | TW202400143A (enExample) |
| WO (1) | WO2023173093A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20240329A1 (es) | 2019-06-05 | 2024-02-27 | Regeneron Pharma | Dispositivos y metodos para administracion de dosis de precision |
| SI4210682T1 (sl) * | 2020-09-14 | 2026-07-31 | EyePoint, Inc. | Bioerozibilni očesni vložek za dovajanje zdravil in terapevtska metoda |
| US12649031B2 (en) | 2021-09-08 | 2026-06-09 | Regeneron Pharmaceuticals, Inc. | Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008033562A2 (en) | 2006-09-15 | 2008-03-20 | Xcovery, Inc. | Kinase inhibitor compounds |
| SG11201901962QA (en) | 2016-09-29 | 2019-04-29 | Equinox Sciences Llc | Polymorphic form of kinase inhibitor compound, pharmaceutical composition containing same, and preparation method therefor and use thereof |
| CA3066437A1 (en) * | 2017-06-13 | 2018-12-20 | EyePoint Pharmaceuticals, Inc. | Bioerodible drug delivery devices |
| US20210340516A1 (en) * | 2020-04-29 | 2021-11-04 | Augusta University Research Institute, Inc. | Compositions containing arginase 1 for the treatment of neurovascular and retinal vascular disorders |
| SI4210682T1 (sl) * | 2020-09-14 | 2026-07-31 | EyePoint, Inc. | Bioerozibilni očesni vložek za dovajanje zdravil in terapevtska metoda |
-
2023
- 2023-03-10 US US18/843,571 patent/US20250186398A1/en active Pending
- 2023-03-10 TW TW112109028A patent/TW202400143A/zh unknown
- 2023-03-10 CA CA3245209A patent/CA3245209A1/en active Pending
- 2023-03-10 AU AU2023230976A patent/AU2023230976A1/en active Pending
- 2023-03-10 KR KR1020247033492A patent/KR20240156416A/ko active Pending
- 2023-03-10 JP JP2024553782A patent/JP2025507154A/ja active Pending
- 2023-03-10 WO PCT/US2023/064148 patent/WO2023173093A1/en not_active Ceased
- 2023-03-10 EP EP23715702.9A patent/EP4489750A1/en active Pending
- 2023-03-10 IL IL315333A patent/IL315333A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023541056A5 (enExample) | ||
| RU2018133133A (ru) | Способ лечения атрофической возрастной макулярной дегенерации | |
| Kahook et al. | Intravitreal bevacizumab in a patient with neovascular glaucoma | |
| CA3025258C (en) | Use of sirolimus to treat exudative age-related macular degeneration with persistent edema | |
| RU2099031C1 (ru) | Система подачи лекарства | |
| JP2002532534A (ja) | 眼内手術における使用のための組成物セット及びキット | |
| JP2024519629A5 (enExample) | ||
| JP2025508127A5 (enExample) | ||
| CN108261390A (zh) | 一种布林佐胺溴莫尼定滴眼液及其制备方法 | |
| CN102058581A (zh) | 一种眼科外用非甾体抗炎药 | |
| CN117159463A (zh) | 治疗青光眼的Wnt5a的调节 | |
| JP2016121163A (ja) | 眼内でのコルチコステロイド使用に伴う眼圧の発生を減少させる方法 | |
| Ahn et al. | Comparison of systemic atracurium, retrobulbar lidocaine, and sub‐Tenon's lidocaine injections in akinesia and mydriasis in dogs | |
| WO2020242264A1 (en) | A composition for treating eye diseases | |
| JP2022547231A5 (enExample) | ||
| Turaka et al. | Intravitreal implant migration into anterior chamber in a post-vitrectomy eye with central retinal vein occlusion and persistent macular edema | |
| Duan et al. | Preliminary study of a controllable device for subtenon drug infusion in a rabbit model | |
| KR102879076B1 (ko) | Sglt-2 억제제를 포함하는 당뇨병성 안질환 예방 또는 치료용 약학적 조성물 | |
| CN116515827A (zh) | 用于治疗年龄相关性黄斑变性的活性成分、药物组合物和应用 | |
| RU1780734C (ru) | Способ коррекции близорукости высокой степени | |
| Chen et al. | Suprachoroidal injection in the treatment of diabetic macular edema: mechanisms, clinical advances, and future perspectives | |
| JP2024531861A (ja) | Ｓｇｌｔ－２阻害剤を含む糖尿病性眼疾患の予防または治療用薬学的組成物 | |
| Ashton | Huge therapeutic advances: Bigger drug delivery opportunities | |
| Scott | Macular edema associated with retinal vein occlusion | |
| RU2675691C1 (ru) | Способ длительной перфузии субтенонового пространства лекарственными средствами |